Women’s Health Technology Show 2024

The Women’s Health Technology Show
10th December 2024

The Women’s Health Technology Show,
2024. London, England.

Meet the leading global experts and innovators in new technologies to detect, diagnose, and manage Women’s Health conditions. Women’s HealthTech Show is for anyone passionately committed to improving health outcomes for women. This event will showcase the innovative technologies being developed to help fast-track the application of solutions to Women’s Health problems.

BUY TICKETS
The Women’s Health Technology Show - Agenda 2024

Time

Session

9:55 - 10:00

Welcome from our Chairperson

Chair person:

Dr Ishi Bains
NHS GP, Regional Primary Care Clinical Lead for Gynaecology

10:00 - 10:45

The Future of Healthcare is Female

Women have historically been underrepresented in research and product development. Our panel will discuss how stakeholders - startups, investors, corporates, and healthcare leaders – have a responsibility to address and championing better healthcare products and services for women by challenging the status quo to create health equity.

Chair person:

Kate Lancaster,
CEO, Royal College of Obstetrics and Gynaecology

Speakers:

Paula Bellostas Mugerza
Senior Partner and Global Healthcare & Life Sciences Practice Leader, Kearney

Alexandra Oti
CoFounder, Unravel Health

Erin Beveridge
Principal Clinical Researcher, Canon Medical Research Europe Ltd.

Miriam Kenrick
CoFounder, Women In Pharma and #BeyondBikiniMedicine

10:45 - 11:30

From Med to MedTech: Adapting the Art of Caregiving in the Digital Revolution

How Health Hubs and AI Can Address Long-Standing Gaps in Women's Health Care While Expanding Access Nationwide

The complexity of women's health care has advanced, but basic needs like accessible contraception are still neglected, contributing to stark disparities in the UK. In this panel, we want to explore how technology can empower women to take an active role in improving their health outcomes through knowledge and access to care. We will be looking at three key topics:
  • Improving early education about menstrual health and addressing prevalent but treatable conditions such as anaemia
  • Harnessing AI to improve the diagnosis of conditions like endometriosis
  • Evolving the model of virtual consultations to make specialist care more accessible across the country

Chair person:

Prof. Dame Lesley Regan
Women’s Health Ambassador England

Speakers:

Dr. Sue Mann
National clinical director for women’s health

Prof. Hilary Critchley
Professor of Reproductive Medicine at UNIVERSITY OF EDINBURGH

Dr. Shera Chok
Founder and Chair of the Shuri Network; National Lead for Community Settings at the NIHR

11:30-12:00

Fertility care

Infertility affects an estimated 186 million individuals globally and many more struggle to conceive. Many technologies are now in place and constantly being developed to aid individuals and couples on their journey.

12:00 - 12:40

Optimising postnatal care and the impact on women’s health

The role of technology and the development of digital health in Postnatal care.
  • The postnatal period is often the time we most neglect women’s health, despite the physical, mental, and emotional health concerns being at their highest.
  • The prevention of long-term conditions and symptoms as a possible consequence of giving birth needs to start early. Preparation is key, and AI and digital consultations can help!
  • The use of technology to help women take ownership of their health, collate patient experience, and the use of these tools to prepare, manage, and support postnatal health.
  • Ensuring the ethnic and economic diversity of our population is at the centre of making the care we give accessible to all women.
  • The women’s health hubs provide collaboration between patients, healthcare professionals, and community services in providing a more holistic method of care.

Chair person:

Dr Ishi Bains
NHS GP, Regional Primary Care Clinical Lead for Gynaecology

Speakers:

Janet Barter
President of the Faculty of sexual and reproductive health and Clinical lead at Tower Hamlets Women’s health Hub

Rehan Khan
Consultant in Obstetrics and Gynaecology, Royal London Hospital Chair, Professional Development Committee at RCOG, Regional Lead Gynaecologist at NHSE (London)

Sunita Sharma
London Postnatal Clinical Lead and Consultant Obstetrician/Gynaecologist at Chelsea and Westminster Hospital

Imogen Pallister
Highly Specialist Physiotherapist, Pelvic Health Team Lead, Barts Health NHS Trust
12:40-13:00

How to deliver exceptional experiences for FemTech startups

The FemTech revolution is reshaping healthcare, bringing women’s health to the forefront and emphasising the need for a user-centric approach that reflects the unique needs of its diverse user base. However, early-stage FemTech startups often struggle to find the best practices for evaluating and designing optimal user experiences. In this session, Shada Azodi, Research Director from Bold Insight—a leading user experience and human factors research agency with offices in London and Chicago—and Dr Sandra Nwokeoha, Founder of Ellescope—a medical software company with the mission to improve antenatal care outcomes—will explore UX research principles tailored specifically for early-stage research and testing. They will share practical tips from real-world projects, demonstrating how effective UX research and design strategies can be used to enhance product usability, accessibility, and satisfaction. Drawing on industry guidelines and their own first-hand experience, Shada and Sandra will offer actionable approaches for startups to anticipate unmet needs, foster empowering user experiences, and drive success in the FemTech sector.

Speakers:

Shada Azodi,
Research Director from Bold Insight

Dr Sandra Nwokeoha,
Founder of Ellescope
13:00-14:30

Lunch and networking

14:30-15:15

Pregnancy and Pharmaceuticals: Bridging the Innovation Gap

Challenges and Opportunities for Innovation in Obstetric Drug Development

The pregnancy market is underexplored but holds significant potential. The market is often seen as risky due to difficulties associated with conducting clinical trials on pregnant patients. However, there is a lot of interest and willingness from the pregnant population to take part in clinical trials. This panel will explore the challenges and opportunities within this market and bust the most commonly associated myths.

Chair person:

Anna David
Director at Institute for Women's Health, University College London

Speakers:

Prof. Jenny Myers
Professor of Obstetrics and Maternal Medicine/Consultant Obstetrician

Prof. Peter Brocklehurst
Emeritus professor of Women’s Health, Director of Research and Development, Birmingham Clinical Trials Unit; Co-chair

Amin Rostami-Hochaghan
Professor of Systems Pharmacology and Director of Centre for Applied Pharmacokinetic Research at The University of Mancheste

Dr Jahnavi Daru
Senior Lecturer at Queen Mary University of London; previously worked for MHRA
15:15 - 17:00

The Women’s Health Technology Show

This is one of the UK’s leading conferences showcasing the innovative technology being developed for women’s health care.
Highlighting the potential of technologies to fast-track solutions to women’s health problems is a key ambition to help reduce the unequal burden of disease women experience.

In the UK, women’s health technology is a rapidly growing sector within healthcare. According to NHS Digital’s 2022 report, greater total costs of patient level activity were related to women than men. Women spend a significantly longer proportion of their lives in ill health and disability when compared with men. Despite this, women are still underrepresented in medical research. Like many other female-specific conditions, research has shown that a lack of menopausal awareness and support for women in the workforce is costing the UK economy £10 billion annually due to affected individuals taking time off and leaving the workforce.
The government’s first Women’s Health Strategy for England was released last year to highlight and reverse the health inequalities and unequal disease burden women experience. Technology plays a key role in fast-tracking the improvement of women’s health outcomes. This show will champion and educate attendees on the technological innovation in women’s health, inspiring more creation and advances in the field.

...
Who is this conference for?

The Women’s Health Tech Show is for all women’s healthcare workers in the UK, innovators and forward-thinking women’s health sector leaders from the healthcare sector, science, technology, and academia; everyone who is passionately committed to improving women’s health.

If you are involved or interested in women's health and tech innovation, this show is for you.

Why attend?

‘This is the UK’s leading MUST ATTEND event for everyone involved in innovation and providing healthcare services in women’s health.

  • Network with high-profile individuals in women’s health
  • Engage with the women’s health technology community
  • Share knowledge with experts in the field
  • Learn about the pertinent issues in women’s health and how technology can help solve them
  • Meet potential customers and buyers

Types of companies this show is for:

Click here for
sponsorship opportunities

The Women’s Health Tech Show is for any companies involved in improving the detection, diagnosis and treatment of women’s health conditions, specifically in the area of:

  • Menstrual health and gynaecological conditions
  • Female-specific and gynaecological cancers
  • Fertility care
  • Maternal health
  • Pelvic floor health
  • Menopause

GIANT Women’s HealthTech Show Board of Advisors

Our advisors who are collaborating with us on building the most impressive and worthwhile show
Giant Health Speaker

Dr Ishi Bains,

NHS GP, Regional Primary Care Clinical Lead for Gynaecology

Giant Health Speaker

Prof. Anna David

Director at Institute for Women's Health, University College London

Giant Health Speaker

Prof. Neena Modi

Professor of Neonatal Medicine, Imperial College London and Chelsea and Westminster NHS Foundation Trust

Giant Health Speaker

Kate Lancaster

CEO at Royal College of Obstetricians and Gynaecologists